Dartmouth Health is offering treatments and preventive therapies for those who are eligible. These treatments and therapies are currently in extremely limited supply.
Treatments are used for those who have already tested positive for COVID-19 and are at high risk of getting severe disease if they are infected with COVID-19.
Dartmouth Health is offering several new treatments for COVID-19 on an outpatient basis. These treatments remain active against all known COVID-19 variants.
Please contact your primary care provider to determine your best treatment option for COVID-19.
As of January 26, 2023, the FDA has revoked the emergency use authorization of Evusheld as a preventive measure against COVID-19 for people who are immunocompromised and at high risk of illness. The most recent research shows that the drug is ineffective against the current strains of COVID-19.
If you are immunocompromised and would like more information, we encourage you to visit the People Who Are Immunocompromised page on the CDC website. This page provides tips on how to protect yourself against COVID-19 and what to do if you do become sick.